Guillain-Barre Syndrome as a Presenting Symptom in Breast Cancer: The Importance of Considering Paraneoplastic Neurologic Syndrome

被引:1
作者
Madala, Samragnyi [1 ]
Macdougall, Kira [2 ]
Morvillo, Gerard [3 ]
Guarino, Robert [3 ]
Sokoloff, Alisa [4 ]
机构
[1] Hofstra Northwell Sch Med, Internal Med, Staten Isl, NY 10305 USA
[2] Northwell Hlth, Internal Med, New York, NY USA
[3] Northwell Hlth, Pathol, New York, NY USA
[4] Northwell Hlth, Hematol Oncol, New York, NY USA
关键词
chemotherapy; breast cancer; paraneoplastic neurologic syndrome; guillain-barre syndrome; malignancy;
D O I
10.7759/cureus.17932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paraneoplastic neurological syndromes (PNS) are a group of rare immune-mediated disorders with neurological sequela in cancer patients. It usually occurs when an immune response against a systemic tumor is incorrectly directed to the nervous system. Compared to other reported manifestations of PNS in breast cancer, Guillain Barre syndrome (GBS) is exceedingly rare. There is only one other reported case in the literature of GBS that was diagnosed in a breast cancer patient. We report the second recorded case of a 61-year-old female with a history of early-stage breast cancer, who presented with symptoms of lower extremity weakness initially suspected to be GBS but later found to have been recurrent breast cancer. No specific guidelines are available for the treatment of PNS. Treatment of underlying malignancy with chemotherapy and immunotherapies are usually recommended.
引用
收藏
页数:6
相关论文
共 12 条
[1]  
[Anonymous], 2019, PARANEOPLASTIC SYNDR
[2]   Immune approaches to the treatment of breast cancer, around the corner? [J].
Criscitiello, Carmen ;
Esposito, Angela ;
Gelao, Lucia ;
Fumagalli, Luca ;
Locatelli, Marzia ;
Minchella, Ida ;
Adamoli, Laura ;
Goldhirsch, Aron ;
Curigliano, Giuseppe .
BREAST CANCER RESEARCH, 2014, 16 (01)
[3]   Paraneoplastic neurological syndromes: clinical presentations and management [J].
Devine, Michelle F. ;
Kothapalli, Naga ;
Elkhooly, Mahmoud ;
Dubey, Divyanshu .
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
[4]   Paraneoplastic neurological complications of breast cancer [J].
Fanous I. ;
Dillon P. .
Experimental Hematology & Oncology, 5 (1)
[5]  
Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447
[6]   Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes [J].
Graus, Francesc ;
Vogrig, Alberto ;
Muniz-Castrillo, Sergio ;
Antoine, Jean-Christophe G. ;
Desestret, Virginie ;
Dubey, Divyanshu ;
Giometto, Bruno ;
Irani, Sarosh R. ;
Joubert, Bastien ;
Leypoldt, Frank ;
McKeon, Andrew ;
Pruss, Harald ;
Psimaras, Dimitri ;
Thomas, Laure ;
Titulaer, Maarten J. ;
Vedeler, Christian A. ;
Verschuuren, Jan J. ;
Dalmau, Josep ;
Honnorat, Jerome .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04)
[7]   Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature [J].
Minisini, Alessandro M. ;
Pauletto, Giada ;
Bergonzi, Paolo ;
Fasola, Gianpiero .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (02) :133-138
[8]   The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested [J].
Ruiz-Garcia, Raquel ;
Martinez-Hernandez, Eugenia ;
Saiz, Albert ;
Dalmau, Josep ;
Graus, Francesc .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[9]   Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249
[10]  
Tuna F, 2016, TURK J GERIATR, V19, P260